small molecule

OPILL

NORGESTREL

Loss of exclusivityJuly 2026FDA regulatory exclusivity expiry

CompanyLABORATOIRE HRA PHARMA

Drug detail

Brand name	OPILL
Active ingredient	NORGESTREL
Strength	0.075MG
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
Marketing status	OTC

Regulatory exclusivity

Code	Expires
RTO	July 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

Drug detail

Regulatory exclusivity

More from LABORATOIRE HRA PHARMA